<p>ITT: intention-to-treat. One subject in the dietary supplement group was lost to follow-up at Month 2, and one subject in the placebo group was withdrawn from the study at Month 2 due to a serious adverse event not related to study treatment (new condition with a need for hormonal treatment).</p
<p>SCT = short cycle therapy, CT = continuous therapy, LTFU = lost to follow-Up. The main trial phas...
<p><sup>a</sup>patients missing outcome data: patients who did not complete effectiveness/safety ass...
<p>The patients who had at least one follow-up visit remained including in the study. </p
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p>One hundred and four patients were screened, of whom 85 were included in the study. One patient w...
<p>Two of the twelve enrolled patients did not complete the trial and therefore were not evaluable b...
<p>Consort Flow Diagram for the KTS-2-2010 study, with enrollment, allocation to induction and maint...
Patients were excluded based on their risk of high grade disease based updated clinical data. PSA me...
ITT: Intention to treat population. PP: per protocol. One participant was lost to follow-up after co...
<p>CONSORT 2010 Flow Diagram. The schema graphically outlines the design and conduct of the clinical...
<p>Patient disposition in (A) the single-dose and multiple-dose dose-escalation phases and (B) the m...
* Of the 6 subjects not treated, 4 subjects did not wish to continue due to reasons unrelated to ass...
*One participant excluded due to exclusionary condition at enrollment. AE, adverse event; CAB, cabot...
<p>This figure shows the loss to follow-up or attrition in the study participants.</p
<p>Study flow diagram and patient attrition according to the CONSORT statement.</p
<p>SCT = short cycle therapy, CT = continuous therapy, LTFU = lost to follow-Up. The main trial phas...
<p><sup>a</sup>patients missing outcome data: patients who did not complete effectiveness/safety ass...
<p>The patients who had at least one follow-up visit remained including in the study. </p
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p>One hundred and four patients were screened, of whom 85 were included in the study. One patient w...
<p>Two of the twelve enrolled patients did not complete the trial and therefore were not evaluable b...
<p>Consort Flow Diagram for the KTS-2-2010 study, with enrollment, allocation to induction and maint...
Patients were excluded based on their risk of high grade disease based updated clinical data. PSA me...
ITT: Intention to treat population. PP: per protocol. One participant was lost to follow-up after co...
<p>CONSORT 2010 Flow Diagram. The schema graphically outlines the design and conduct of the clinical...
<p>Patient disposition in (A) the single-dose and multiple-dose dose-escalation phases and (B) the m...
* Of the 6 subjects not treated, 4 subjects did not wish to continue due to reasons unrelated to ass...
*One participant excluded due to exclusionary condition at enrollment. AE, adverse event; CAB, cabot...
<p>This figure shows the loss to follow-up or attrition in the study participants.</p
<p>Study flow diagram and patient attrition according to the CONSORT statement.</p
<p>SCT = short cycle therapy, CT = continuous therapy, LTFU = lost to follow-Up. The main trial phas...
<p><sup>a</sup>patients missing outcome data: patients who did not complete effectiveness/safety ass...
<p>The patients who had at least one follow-up visit remained including in the study. </p